BAL PHARMA
|
BAL PHARMA Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr |
Equity - Authorised | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹15 Cr |
Equity - Issued | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr |
Equity Paid Up | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | ₹0.94 Cr | ₹0.94 Cr | - | - |
Total Reserves | ₹48 Cr | ₹43 Cr | ₹38 Cr | ₹38 Cr | ₹52 Cr |
Securities Premium | ₹32 Cr | ₹28 Cr | ₹27 Cr | ₹24 Cr | ₹24 Cr |
Capital Reserves | ₹0.44 Cr | ₹0.44 Cr | ₹0.44 Cr | ₹0.44 Cr | ₹0.44 Cr |
Profit & Loss Account Balance | ₹15 Cr | ₹14 Cr | ₹9.45 Cr | ₹13 Cr | ₹27 Cr |
General Reserves | ₹2.45 Cr | ₹2.45 Cr | ₹2.45 Cr | ₹2.45 Cr | ₹2.45 Cr |
Other Reserves | ₹-0.97 Cr | ₹-1.20 Cr | ₹-1.20 Cr | ₹-1.30 Cr | ₹-1.01 Cr |
Reserve excluding Revaluation Reserve | ₹48 Cr | ₹43 Cr | ₹38 Cr | ₹38 Cr | ₹52 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹64 Cr | ₹59 Cr | ₹54 Cr | ₹52 Cr | ₹67 Cr |
Minority Interest | ₹-0.09 Cr | ₹-0.13 Cr | ₹-0.23 Cr | ₹-7.10 Cr | ₹-6.42 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹31 Cr | ₹27 Cr | ₹24 Cr | ₹23 Cr | ₹29 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹12 Cr | ₹12 Cr | ₹15 Cr | ₹12 Cr | ₹16 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹18 Cr | ₹15 Cr | ₹8.69 Cr | ₹11 Cr | ₹13 Cr |
Unsecured Loans | - | - | - | ₹0.22 Cr | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | ₹0.12 Cr | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | ₹0.10 Cr | - |
Deferred Tax Assets / Liabilities | ₹0.70 Cr | ₹0.60 Cr | ₹2.63 Cr | ₹3.58 Cr | ₹4.18 Cr |
Deferred Tax Assets | ₹4.89 Cr | ₹4.58 Cr | ₹4.51 Cr | ₹3.90 Cr | ₹1.64 Cr |
Deferred Tax Liability | ₹5.59 Cr | ₹5.18 Cr | ₹7.15 Cr | ₹7.49 Cr | ₹5.82 Cr |
Other Long Term Liabilities | ₹1.68 Cr | ₹4.08 Cr | ₹3.56 Cr | ₹3.21 Cr | ₹2.20 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹5.07 Cr | ₹4.69 Cr | ₹4.07 Cr | ₹3.62 Cr | ₹2.71 Cr |
Total Non-Current Liabilities | ₹38 Cr | ₹36 Cr | ₹34 Cr | ₹34 Cr | ₹38 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹79 Cr | ₹66 Cr | ₹47 Cr | ₹39 Cr | ₹47 Cr |
Sundry Creditors | ₹79 Cr | ₹66 Cr | ₹47 Cr | ₹39 Cr | ₹47 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹31 Cr | ₹24 Cr | ₹24 Cr | ₹31 Cr | ₹28 Cr |
Bank Overdraft / Short term credit | - | - | ₹1.30 Cr | ₹1.17 Cr | ₹3.95 Cr |
Advances received from customers | ₹12 Cr | ₹6.28 Cr | ₹5.97 Cr | ₹11 Cr | ₹7.88 Cr |
Interest Accrued But Not Due | ₹0.18 Cr | ₹0.47 Cr | ₹0.47 Cr | ₹0.14 Cr | ₹0.17 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹19 Cr | ₹16 Cr |
Short Term Borrowings | ₹93 Cr | ₹71 Cr | ₹81 Cr | ₹90 Cr | ₹87 Cr |
Secured ST Loans repayable on Demands | ₹87 Cr | ₹65 Cr | ₹75 Cr | ₹70 Cr | ₹68 Cr |
Working Capital Loans- Sec | ₹87 Cr | ₹65 Cr | ₹75 Cr | ₹66 Cr | ₹68 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-81 Cr | ₹-59 Cr | ₹-69 Cr | ₹-47 Cr | ₹-49 Cr |
Short Term Provisions | ₹6.64 Cr | ₹5.12 Cr | ₹0.98 Cr | ₹0.50 Cr | ₹0.96 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹6.01 Cr | ₹4.39 Cr | ₹0.32 Cr | - | ₹0.46 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.64 Cr | ₹0.73 Cr | ₹0.66 Cr | ₹0.50 Cr | ₹0.51 Cr |
Total Current Liabilities | ₹209 Cr | ₹166 Cr | ₹153 Cr | ₹159 Cr | ₹163 Cr |
Total Liabilities | ₹311 Cr | ₹261 Cr | ₹240 Cr | ₹238 Cr | ₹261 Cr |
ASSETS | |||||
Gross Block | ₹127 Cr | ₹111 Cr | ₹105 Cr | ₹98 Cr | ₹90 Cr |
Less: Accumulated Depreciation | ₹51 Cr | ₹44 Cr | ₹37 Cr | ₹27 Cr | ₹19 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹76 Cr | ₹67 Cr | ₹69 Cr | ₹71 Cr | ₹70 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | ₹1.61 Cr | - | ₹3.32 Cr | ₹3.63 Cr |
Non Current Investments | - | - | - | - | ₹0.02 Cr |
Long Term Investment | - | - | - | - | ₹0.02 Cr |
Quoted | ₹0.11 Cr | ₹0.11 Cr | ₹0.11 Cr | - | - |
Unquoted | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | - | ₹0.02 Cr |
Long Term Loans & Advances | ₹4.61 Cr | ₹5.01 Cr | ₹4.86 Cr | ₹5.43 Cr | ₹1.69 Cr |
Other Non Current Assets | ₹1.78 Cr | ₹1.95 Cr | ₹2.49 Cr | ₹1.56 Cr | ₹2.54 Cr |
Total Non-Current Assets | ₹83 Cr | ₹76 Cr | ₹76 Cr | ₹81 Cr | ₹78 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹98 Cr | ₹74 Cr | ₹60 Cr | ₹68 Cr | ₹70 Cr |
Raw Materials | ₹36 Cr | ₹31 Cr | ₹23 Cr | ₹25 Cr | ₹22 Cr |
Work-in Progress | ₹27 Cr | ₹18 Cr | ₹12 Cr | ₹6.48 Cr | ₹18 Cr |
Finished Goods | ₹29 Cr | ₹20 Cr | ₹21 Cr | ₹32 Cr | ₹24 Cr |
Packing Materials | ₹5.36 Cr | ₹4.88 Cr | ₹4.16 Cr | ₹4.11 Cr | ₹5.42 Cr |
Stores Ā and Spare | ₹0.07 Cr | ₹0.05 Cr | ₹0.04 Cr | ₹0.13 Cr | ₹0.13 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹94 Cr | ₹75 Cr | ₹67 Cr | ₹50 Cr | ₹65 Cr |
Debtors more than Six months | ₹1.46 Cr | ₹0.91 Cr | - | - | - |
Debtors Others | ₹94 Cr | ₹75 Cr | ₹68 Cr | ₹50 Cr | ₹65 Cr |
Cash and Bank | ₹7.61 Cr | ₹5.39 Cr | ₹3.85 Cr | ₹3.13 Cr | ₹4.32 Cr |
Cash in hand | ₹0.03 Cr | ₹0.03 Cr | ₹0.20 Cr | ₹0.28 Cr | ₹0.16 Cr |
Balances at Bank | ₹7.58 Cr | ₹5.37 Cr | ₹3.65 Cr | ₹2.86 Cr | ₹4.17 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹3.73 Cr | ₹12 Cr | ₹4.69 Cr | ₹4.07 Cr | ₹0.70 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | ₹6.17 Cr | - | - | - |
Prepaid Expenses | ₹0.72 Cr | ₹0.59 Cr | ₹0.08 Cr | ₹0.33 Cr | ₹0.70 Cr |
Other current_assets | ₹3.01 Cr | ₹5.74 Cr | ₹4.61 Cr | ₹3.74 Cr | - |
Short Term Loans and Advances | ₹25 Cr | ₹17 Cr | ₹28 Cr | ₹33 Cr | ₹44 Cr |
Advances recoverable in cash or in kind | ₹6.48 Cr | ₹4.32 Cr | ₹9.42 Cr | ₹21 Cr | ₹23 Cr |
Advance income tax and TDS | ₹0.15 Cr | ₹0.10 Cr | ₹0.02 Cr | ₹0.11 Cr | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹18 Cr | ₹13 Cr | ₹19 Cr | ₹11 Cr | ₹20 Cr |
Total Current Assets | ₹228 Cr | ₹185 Cr | ₹164 Cr | ₹157 Cr | ₹183 Cr |
Net Current Assets (Including Current Investments) | ₹19 Cr | ₹19 Cr | ₹12 Cr | ₹-2.12 Cr | ₹20 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹311 Cr | ₹261 Cr | ₹240 Cr | ₹238 Cr | ₹261 Cr |
Contingent Liabilities | ₹16 Cr | ₹16 Cr | ₹13 Cr | ₹13 Cr | ₹20 Cr |
Total Debt | ₹131 Cr | ₹104 Cr | ₹110 Cr | ₹118 Cr | ₹124 Cr |
Book Value | 40.66 | 38.92 | 35.52 | 36.99 | 47.02 |
Adjusted Book Value | 40.66 | 38.92 | 35.52 | 36.99 | 47.02 |
Compare Balance Sheet of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹159.4 Cr | 4.2% | -15.4% | 42.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 4.2% |
-15.4% |
42.3% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses